Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)

被引：9

作者：

Halland, Nis ^{[1
]}

Czech, Joerg ^{[1
]}

Czechtizky, Werngard ^{[1
]}

Evers, Andreas ^{[1
]}

Follmann, Markus ^{[1
,2
]}

Kohlmann, Markus ^{[1
]}

Schreuder, Herman A. ^{[1
]}

Kallus, Christopher ^{[1
,3
]}

机构：

[1] Sanofi R&D, Ind Pk Hochst Bldg G838, D-65926 Frankfurt, Germany

[2] Bayer Pharma AG, Aprather Weg 18A, D-42113 Wuppertal, Germany

[3] Bayer Cropsci, Ind Pk Hochst Bldg G836, D-65926 Frankfurt, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2016年 / 59卷 / 20期

关键词：

PROCARBOXYPEPTIDASE-B; CARBOXYPEPTIDASE-N; ARGININE; PLASMA; TARGET; STATE;

D O I：

10.1021/acs.jmedchem.6b01276

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Previously disclosed TAFIa inhibitors having a urea zinc-binding motif were used as the starting point for the development of a novel class of highly potent inhibitors having a sulfamide zinc-binding motif. High-resolution X-ray cocrystal structures were used to optimize the structures and reveal a highly unusual sulfamide configuration. A selected sulfamide was profiled in vitro and in vivo and displayed a promising ADMET profile.

引用

页码：9567 / 9573

页数：7

共 50 条

[31] A first-in-human, single ascending dose study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor (TAFIa), in healthy subjects
Zhou, J.
Zamora, C.
Atiee, G.
Warren, V
Yin, O.
Kochan, J.
Pav, J.
Orihashi, Y.
Vashi, V.
Dishy, V
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 487 - 487
[32] Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Bazzi, Zainab A.
Lanoue, Danielle
El-Youssef, Mouhanned
Romagnuolo, Rocco
Tubman, Janice
Cavallo-Medved, Dora
Porter, Lisa A.
Boffa, Michael B.
BMC CANCER, 2016, 16
[33] Identification of Thrombomodulin Binding Sites on Thrombin Activatable Fibrinolysis Inhibitor that Mediate Accelerated Activation by Thrombin
Marar, Tanya
Boffa, Michael B.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
[34] Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Zainab A. Bazzi
Danielle Lanoue
Mouhanned El-Youssef
Rocco Romagnuolo
Janice Tubman
Dora Cavallo-Medved
Lisa A. Porter
Michael B. Boffa
BMC Cancer, 16
[35] Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects
Dop, F. Petit
Latreille, M.
Guicherd, L.
Mertens, J. C.
Claesen, K.
Hendriks, D.
Arnaud, E.
Donazzolo, Y.
EUROPEAN HEART JOURNAL, 2020, 41 : 2268 - 2268
[36] Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites
Foley, Jonathan H.
Cook, Paul F.
Nesheim, Michael E.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (22) : 19280 - 19286
[37] Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor
Sanglas, L.
Arolas, J. L.
Valnickova, Z.
Aviles, F. X.
Enghild, J. J.
Gomis-Ruth, F. X.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) : 1056 - 1065
[38] Discovery of novel mechanisms and molecular targets for the inhibition of activated thrombin activatable fibrinolysis inhibitor
Hillmayer, K.
Vancraenenbroeck, R.
De Maeyer, M.
Compernolle, G.
Declerck, P. J.
Gils, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 1892 - 1899
[39] Conformational (in)stability of rat vs. human activated thrombin activatable fibrinolysis inhibitor
Hillmayer, K.
Ceresa, E.
Vancraenenbroeck, R.
Declerck, P. J.
Gils, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) : 1426 - 1428
[40] DS-1040: a novel selective inhibitor of activated form of thrombin-activatable fibrinolysis inhibitor
Noguchi, K.
Edo, N.
Ito, Y.
Maejima, T.
Yamaguchi, K.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 336 - 336

← 1 2 3 4 5 →